American Heart Journal
Volume 156, Issue 6 , Pages 1117-1123 , December 2008

Omega-6 and trans fatty acids in blood cell membranes: A risk factor for acute coronary syndromes?

  • Robert C. Block, MD, MPH

      Affiliations

    • Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY
    • Corresponding Author InformationReprint requests: Robert C. Block, MD, MPH, Division of Epidemiology, Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Box 644, 601 Elmwood Avenue, Rochester, NY 14642.
    • ,
  • William S. Harris, PhD

      Affiliations

    • Division of Cardiovascular Research, Saint Luke's Mid America Heart Institute
    • Department of Medicine, University of Missouri-Kansas City, Kansas City, MO
    • ,
  • Kimberly J. Reid, MS

      Affiliations

    • Division of Cardiovascular Research, Saint Luke's Mid America Heart Institute
    • ,
  • John A. Spertus, MD, MPH

      Affiliations

    • Division of Cardiovascular Research, Saint Luke's Mid America Heart Institute
    • Department of Medicine, University of Missouri-Kansas City, Kansas City, MO

Received 6 May 2008 ,Accepted 19 July 2008.

References 

  1. Lemaitre RN, King IB, Mozaffarian D, et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the Cardiovascular Health Study. Circulation. 2006;114:209–215
  2. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491–1499
  3. Kromhout D, Menotti A, Bloemberg B, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med. 1995;24:308–315
  4. Oh K, Hu FB, Manson JE, et al. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses' Health Study. Am J Epidemiol. 2005;161:672–679
  5. Ascherio A, Hennekens CH, Buring JE, et al. Trans-fatty acids intake and risk of myocardial infarction. Circulation. 1994;89:94–101
  6. Baylin A, Kabagambe EK, Ascherio A, et al. High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J Nutr. 2003;133:1186–1191
  7. Clifton PM, Keogh JB, Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr. 2004;134:874–879
  8. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–1118
  9. Aro A, Kardinaal AF, Salminen I, et al. Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet. 1995;345:273–278
  10. Roberts TL, Wood DA, Riemersma RA, et al. Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet. 1995;345:278–282
  11. Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 2002;113(Suppl 9B):13S–24S
  12. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006;60:502–507
  13. In:  Shils ME,  Ross AC,  Caballero B, et al. editor. Modern nutrition in health and disease. 10th ed.. Baltimore (Md): Lippincott Williams and Wilkins; 2006;
  14. Block RC, Harris WS, Reid KJ, et al. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis. 2008;197:821–828
  15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  16. Harrell FE. Regression modeling strategies with applications to linear models, logistic regression and survival analysis. 1st ed.. New York (NY): Springer-Verlag; 2001;
  17. Lemieux I, Lamarche B, Couillard C, et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med. 2001;161:2685–2692
  18. Sun Q, Ma J, Campos H, et al. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation. 2007;115:1858–1865
  19. Harris WS. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep. 2006;8:453–459
  20. Stanley JC, Elsom RL, Calder PC, et al. UK food standards agency workshop report: the effects of the dietary n-6:n-3 fatty acid ratio on cardiovascular health. Br J Nutr. 2007;98:1305–1310
  21. Mensink RP, Zock PL, Kester AD, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146–1155
  22. In:  Willett WC editors. Nutritional epidemiology. 2nd ed.. Oxford University Press; 1998;
  23. Morris JN, Ball KP, Antonis A. Controlled trial of soya-bean oil in myocardial infarction. Lancet. 1968;2:693–699
  24. Dayton S, Pearce ML, Hashimoto S, et al. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation. 1969;40:1–63
  25. Leren P. The Oslo Diet-Heart Study. Acta Med Scand. 1966;466(Suppl):5–92
  26. Turpeinen O, Karvonen MJ, Pekkarinen M, et al. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol. 1979;8:99–118
  27. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease: the Western Electric Study. N Engl J Med. 1981;304:65–70
  28. McGee DL, Reed DM, Yano K, et al. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: Relationship to nutrient intake. Am J Epidemiol. 1984;119:667–676
  29. Goldbourt U, Yaari S, Medalie JH. Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. Cardiol. 1993;82:100–121
  30. Laaksonen DE, Nyyssonen K, Niskanen L, et al. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med. 2005;165:193–199
  31. Jurand J, Oliver MF. Effects of acute myocardial infarction and of noradrenaline infusion on fatty acid composition of serum lipids. Atherosclerosis. 1970;11:157–170
  32. Kark JD, Manor O, Goldman S, et al. Stability of red blood cell membrane fatty acid composition after acute myocardial infarction. J Clin Epidemiol. 1995;48:889–895
  33. Wijendran V, Hayes KC. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr. 2004;24:597–615
  34. Mozaffarian D, Katan MB, Ascherio A, et al. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–1613
  35. Lemaitre RN, King IB, Raghunathan TE, et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation. 2002;105:697–701
  36. Blanck HM, Bowman BA, Cooper GR, et al. Laboratory issues: use of nutritional biomarkers. J Nutr. 2003;133(Suppl 3):888S–894S
  37. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 2007;193:1–10
  38. Hjelte LE, Nilsson A. Arachidonic acid and ischemic heart disease. J Nutr. 2005;135:2271–2273
  39. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  40. Chambless LE, Folsom AR, Sharrett AR, et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) Study. J Clin Epidemiol. 2003;56:880–890
  41. Harris WS, von Schacky C. The Omega-3 index: a new risk factor for death from coronary heart disease?. Preventive Medicine. 2004;39:212–220
  42. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349–361
  43. Ferrucci L, Cherubini A, Bandinelli S, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab. 2006;91:439–446

 This study received funding from the following sources: (1) The Saint Luke's Hospital Foundation, Kansas City, MO; (2) grant KL2 RR 024136 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. The contents of this study are solely the responsibility of the authors and do not necessarily represent the official view of the NCRR or NIH. Information on NCRR is available at http://www.ncrr.nih.gov/. Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp.

PII: S0002-8703(08)00647-9

doi: 10.1016/j.ahj.2008.07.014

American Heart Journal
Volume 156, Issue 6 , Pages 1117-1123 , December 2008

Article Tools

* Image Usage & Resolution